查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲 PCR 技术市场预测至 2030 年 - 区域分析 - 按技术、产品、应用和最终用户
市场调查报告书
商品编码
1562195

欧洲 PCR 技术市场预测至 2030 年 - 区域分析 - 按技术、产品、应用和最终用户

Europe PCR Technologies Market Forecast to 2030 - Regional Analysis - by Technology, Offerings, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 147 Pages | 订单完成后即时交付

价格

欧洲PCR技术市场预计将从2022年的38.8013亿美元成长到2030年的71.7373亿美元。

新兴国家越来越多地采用 PCR 技术推动欧洲 PCR 技术市场

即时 (POC) 检测透过扩大其范围和应用，为 PCR 技术市场带来了重大机会。 PCR 技术以其准确性和灵敏度而闻名，由于能够在护理点或附近提供快速可靠的结果，因此越来越多地应用于 POC 测试。随着 POC 测试在诊所、急诊室和分散设施等医疗机构中变得越来越普遍，针对 POC 应用客製化的 PCR 平台和检测的需求预计将会增加。

PCR 的优势，包括能够以高特异性和敏感性检测传染病，使其非常适合 POC 检测，特别是在需要快速诊断和治疗决策的情况下。此外，PCR 系统的小型化和自动化进一步使其能够整合到 POC 设置中，促进现场测试并改善患者护理结果。随着医疗保健提供者越来越认识到 POC PCR 检测在增强诊断能力和患者管理方面的价值，POC PCR 技术市场有望实现成长和创新。

欧洲 PCR 技术市场概况

欧洲 PCR 技术市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。政府和私人组织为高级研究提供的资金、人工 DNA 合成创新技术的推出以及基于新技术的应用的各种研究的增加推动了欧洲 PCR 技术市场的成长。此外，各国政府透过对研发和新生物技术新创企业的激励措施和免税来鼓励创新，预计将有利于欧洲 PCR 技术市场在预测期内的成长。德国是欧洲和全球最大的生物技术中心之一，拥有着名的生物技术企业、高科技研究实验室以及用于在新科学技术领域开展研发活动的大量资金。该国拥有的生物技术公司比其他欧洲国家都多。德国正在进行的尖端和高品质研究为已经建立的 PCR 技术市场创造了利润丰厚的机会。该国的个人研究人员和学术大学与国际实验室和机构合作，创造突破性创新。资金和补助金的增加以及合成生物学在各个应用领域的使用不断增加是有利于德国 PCR 技术市场成长的主要因素。德国政府认为新创企业的组成是该国生物技术产业发展的重要组成部分。例如，BIO Deutschland 是德国生物技术产业的产业协会，总部位于柏林，拥有 330 多名会员，致力于促进和支持该产业的发展，帮助其发展成为一个强大的经济实体。同样，泛欧交易所是另一个认识并利用生物技术产业当前势头的组织。因此，它透过创造就业机会、筹集资金和投资以及以各种其他方式支持公司来帮助新创公司。

欧洲 PCR 技术市场收入及 2030 年预测（百万美元）

欧洲 PCR 技术市场细分

欧洲 PCR 技术市场分为技术、产品、应用、最终用户和国家。

依技术，欧洲PCR技术市场分为即时PCR、常规PCR、逆转录、数位PCR、多重RTPCR、热启动PCR等。 2022 年，即时 PCR 领域在欧洲 PCR 技术市场中占据最大份额。

在产品方面，欧洲 PCR 技术市场分为试剂和耗材、仪器以及软体和服务。到2022年，试剂和耗材细分市场在欧洲PCR技术市场中占据最大份额。此外，西林瓶尺寸分为0.2ml至2ml、0.1ml至0.3ml、2ml至5ml等西林瓶。此外，仪器部分分为桌上型 PCR 和便携式热循环仪/PCR。

依应用划分，欧洲 PCR 技术市场分为基因表现分析、基因定序、基因分型、核酸合成、标准验证、护理点诊断应用、环境应用等。 2022 年，基因表现分析领域占据欧洲 PCR 技术市场的最大份额。

根据最终用户，欧洲 PCR 技术市场分为医院和诊断中心、製药和生物技术公司、学术机构和研究实验室等。 2022 年，医院和诊断中心细分市场占据欧洲 PCR 技术市场的最大份额。

依国家/地区划分，欧洲 PCR 技术市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。 2022 年，德国在欧洲 PCR 技术市场占据主导地位。

Thermo Fisher Scientific Inc、Promega Corp、QIAGEN NV、bioMerieux SA、Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Becton Dickinson and Co、Takara Bio Inc、Standard Bio Tools Inc、Agilent Technologies Inc 和 Ellume Ltd 等在欧洲PCR技术市场营运的领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：欧洲 PCR 技术市场 - 主要产业动态

  • PCR 技术市场 - 主要产业动态
  • 市场驱动因素
    • 遗传性疾病和传染病的盛行率不断上升
    • PCR 技术的投资和资金供应激增
  • 市场限制
    • PCR 系统的高成本和替代检测的可用性
  • 市场机会
    • POC 测试需求不断增加
  • 未来趋势
    • PCR 技术的进步
  • 驱动因素和限制的影响：

第 5 章：PCR 技术市场 - 欧洲市场分析

  • PCR 技术市场收入，2020 - 2030

第 6 章：欧洲 PCR 技术市场分析 - 按技术

  • 概述
  • 实时萤光定量PCR
  • 常规PCR
  • 逆转录聚合酶连锁反应
  • 数位PCR
  • 多重逆转录聚合酶连锁反应
  • 热启动PCR
  • 其他的

第 7 章：欧洲 PCR 技术市场分析 - 按产品

  • 概述
  • 2022 年和 2030 年 PCR 技术市场收入份额（按产品划分）（%）
  • 试剂及耗材
  • 仪器仪表
  • 软体和服务

第 8 章：欧洲 PCR 技术市场分析 - 按应用

  • 概述
  • 2022 年和 2030 年 PCR 技术市场收入份额，按应用划分 (%)
  • 基因表现分析
  • 基因定序
  • 基因分型
  • 核酸合成
  • 标准验证
  • 护理点诊断
  • 环境应用
  • 其他的

第 9 章：欧洲 PCR 技术市场分析 - 按最终用户

  • 概述
  • 2022 年和 2030 年 PCR 技术市场收入份额（按最终用户划分）（%）
  • 医院和诊断中心
  • 学术界及研究机构
  • 製药和生物技术公司
  • 其他的

第 10 章：欧洲 PCR 技术市场 - 国家分析

  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区

第 11 章：PCR 技术市场-产业格局

  • 概述
  • PCR 技术市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 12 章：公司简介

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • QIAGEN NV
  • bioMerieux SA
  • Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Becton Dickinson and Co
  • Takara Bio Inc
  • Standard Biotools Inc
  • Agilent Technologies Inc
  • Ellume Ltd

第 13 章：附录

Product Code: BMIRE00030425

The Europe PCR technologies market is expected to grow from US$ 3,880.13 million in 2022 to US$ 7,173.73 million by 2030. It is estimated to record a CAGR of 8.0% from 2022 to 2030.

Increasing Adoption of PCR Techniques in Emerging Countries Drives Europe PCR Technologies Market

Point-of-care (POC) testing presents a significant opportunity for the PCR technology market by expanding its reach and applications. PCR technology, known for its accuracy and sensitivity, is increasingly being adapted for POC testing due to its ability to deliver rapid and reliable results at or near the point of care. As POC testing becomes more prevalent in healthcare settings such as clinics, emergency departments, and decentralized facilities, the demand for PCR platforms and assays tailored for POC applications is expected to rise.

PCR's advantages, including the ability to detect infectious diseases with high specificity and sensitivity, make it well-suited for POC testing, particularly in situations requiring rapid diagnosis and treatment decisions. Additionally, the miniaturization and automation of PCR systems further enable their integration into POC settings, facilitating on-site testing and improving patient care outcomes. As healthcare providers increasingly recognize the value of POC PCR testing in enhancing diagnostic capabilities and patient management, the market for POC PCR technologies is poised for growth and innovation.

Europe PCR Technologies Market Overview

The European PCR technologies market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Funds made available by government and private organizations for advanced research, the launch of innovative technologies for artificial DNA synthesis, and an increase in various research studies for novel technology-based applications drive the growth of the PCR technologies market in Europe. In addition, efforts taken by the national governments to encourage innovation through incentive provisions and tax exemptions for R&D and new biotech start-ups are expected to favour the European PCR technologies market growth over the forecast period. Germany is one of the largest biotechnology hubs in Europe and worldwide owing to the presence of prominent biotech players, high-tech research labs, and massive funding for conducting research and development activities in the new areas of science and technology. The country has more biotechnology companies than any other European country. The cutting-edge and high-quality research ongoing in Germany creates lucrative opportunities for the already established market for PCR technologies. Individual researchers and academic universities in the country collaborate with international laboratories and institutions to create breakthrough innovations. The rising funds and grants and increasing use of synthetic biology in various application areas are the major factors favoring the growth of the German PCR technologies market. The German government considers the formation of startups to be an essential part of the development of the biotechnology industry in the country. For instance, BIO Deutschland is a sector association of the German biotech industry based in Berlin, with over 330 members that promote and support the development of the industry to help it bloom as a robust economic entity. Similarly, Euronext is another organization that recognizes and utilizes the current momentum of the biotech industry. It thus assists startups by creating jobs, raising funds and investments, and supporting the companies in various other ways.

Europe PCR Technologies Market Revenue and Forecast to 2030 (US$ Million)

Europe PCR Technologies Market Segmentation

The Europe PCR technologies market is segmented into technology, offerings, application, end user, and country.

Based on technology, the Europe PCR technologies market is categorized into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held the largest share of Europe PCR technologies market in 2022.

In terms of offerings, the Europe PCR technologies market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of Europe PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR.

By application, the Europe PCR technologies market is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of Europe PCR technologies market in 2022.

Based on end user, the Europe PCR technologies market is segmented into hospitals & diagnostic centres, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centres segment held the largest share of Europe PCR technologies market in 2022.

By country, the Europe PCR technologies market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe PCR technologies market in 2022.

Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, Agilent Technologies Inc, and Ellume Ltd are some of the leading companies operating in the Europe PCR technologies market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe PCR Technologies Market - Key Industry Dynamics

  • 4.1 PCR Technologies Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Genetic and Infectious Diseases
    • 4.2.2 Surging Investments and Funds Availability for PCR Technologies
  • 4.3 Market Restraints
    • 4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
  • 4.4 Market Opportunities
    • 4.4.1 Increasing Demand for POC Testing
  • 4.5 Future Trends
    • 4.5.1 Advancements in PCR Technologies
  • 4.6 Impact of Drivers and Restraints:

5. PCR Technologies Market - Europe Market Analysis

  • 5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030

6. Europe PCR Technologies Market Analysis - By Technology

  • 6.1 Overview
  • 6.2 Real Time PCR
    • 6.2.1 Overview
    • 6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.3 Conventional PCR
    • 6.3.1 Overview
    • 6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Reverse Transcription PCR
    • 6.4.1 Overview
    • 6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Digital PCR
    • 6.5.1 Overview
    • 6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Multiplex RT PCR
    • 6.6.1 Overview
    • 6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.7 Hot Start PCR
    • 6.7.1 Overview
    • 6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Others
    • 6.8.1 Overview
    • 6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

7. Europe PCR Technologies Market Analysis - By Offerings

  • 7.1 Overview
  • 7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
  • 7.3 Reagents and Consumables
    • 7.3.1 Overview
    • 7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
        • 7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • 7.4 Instruments
    • 7.4.1 Overview
    • 7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
      • 7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • 7.5 Software and Services
    • 7.5.1 Overview
    • 7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)

8. Europe PCR Technologies Market Analysis - By Application

  • 8.1 Overview
  • 8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Gene Expression Analysis
    • 8.3.1 Overview
    • 8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Genetic Sequencing
    • 8.4.1 Overview
    • 8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Genotyping
    • 8.5.1 Overview
    • 8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Nucleic Acid Synthesis
    • 8.6.1 Overview
    • 8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Standard Validation
    • 8.7.1 Overview
    • 8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Point of Care Diagnostics
    • 8.8.1 Overview
    • 8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.9 Environmental Application
    • 8.9.1 Overview
    • 8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.10 Others
    • 8.10.1 Overview
    • 8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. Europe PCR Technologies Market Analysis - By End User

  • 9.1 Overview
  • 9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals and Diagnostic Centers
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Academia and Research Institutes
    • 9.4.1 Overview
    • 9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Pharmaceutical and Biotechnology Companies
    • 9.5.1 Overview
    • 9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

10. Europe PCR Technologies Market -Country Analysis

  • 10.1 Europe: PCR Technologies Market
    • 10.1.1 Overview
    • 10.1.2 Europe PCR Technologies Market Revenue and Forecast and Analysis - By Country
      • 10.1.2.1 Germany
        • 10.1.2.1.1 Overview
      • 10.1.2.2 Germany PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.1 Germany PCR Technologies Market Breakdown by Technology
        • 10.1.2.2.2 Germany PCR Technologies Market Breakdown by Offerings
        • 10.1.2.2.2.1 Germany PCR Technologies Market Breakdown by Instruments
        • 10.1.2.2.2.2 Germany PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.2.2.2.1 Germany PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.2.3 Germany PCR Technologies Market Breakdown by Application
        • 10.1.2.2.4 Germany PCR Technologies Market Breakdown by End User
      • 10.1.2.3 United Kingdom
        • 10.1.2.3.1 Overview
      • 10.1.2.4 United Kingdom PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.4.1 United Kingdom PCR Technologies Market Breakdown by Technology
        • 10.1.2.4.2 United Kingdom PCR Technologies Market Breakdown by Offerings
        • 10.1.2.4.2.1 United Kingdom PCR Technologies Market Breakdown by Instruments
        • 10.1.2.4.2.2 United Kingdom PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.4.2.2.1 United Kingdom PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.4.3 United Kingdom PCR Technologies Market Breakdown by Application
        • 10.1.2.4.4 United Kingdom PCR Technologies Market Breakdown by End User
      • 10.1.2.5 France
        • 10.1.2.5.1 Overview
      • 10.1.2.6 France PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.1 France PCR Technologies Market Breakdown by Offerings
        • 10.1.2.6.1.1 France PCR Technologies Market Breakdown by Instruments
        • 10.1.2.6.1.2 France PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.6.1.2.1 France PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.6.2 France PCR Technologies Market Breakdown by Application
        • 10.1.2.6.3 France PCR Technologies Market Breakdown by End User
      • 10.1.2.7 Italy
        • 10.1.2.7.1 Overview
      • 10.1.2.8 Italy PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.8.1 Italy PCR Technologies Market Breakdown by Technology
        • 10.1.2.8.2 Italy PCR Technologies Market Breakdown by Offerings
        • 10.1.2.8.2.1 Italy PCR Technologies Market Breakdown by Instruments
        • 10.1.2.8.2.2 Italy PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.8.2.2.1 Italy PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.8.3 Italy PCR Technologies Market Breakdown by Application
        • 10.1.2.8.4 Italy PCR Technologies Market Breakdown by End User
      • 10.1.2.9 Spain
        • 10.1.2.9.1 Overview
      • 10.1.2.10 Spain PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.10.1 Spain PCR Technologies Market Breakdown by Technology
        • 10.1.2.10.2 Spain PCR Technologies Market Breakdown by Offerings
        • 10.1.2.10.2.1 Spain PCR Technologies Market Breakdown by Instruments
        • 10.1.2.10.2.2 Spain PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.10.2.2.1 Spain PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.10.3 Spain PCR Technologies Market Breakdown by Application
        • 10.1.2.10.4 Spain PCR Technologies Market Breakdown by End User
      • 10.1.2.11 Rest of Europe
        • 10.1.2.11.1 Overview
      • 10.1.2.12 Rest of Europe PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.12.1 Rest of Europe PCR Technologies Market Breakdown by Technology
        • 10.1.2.12.2 Rest of Europe PCR Technologies Market Breakdown by Offerings
        • 10.1.2.12.2.1 Rest of Europe PCR Technologies Market Breakdown by Instruments
        • 10.1.2.12.2.2 Rest of Europe PCR Technologies Market Breakdown by Reagents and Consumables
        • 10.1.2.12.2.2.1 Rest of Europe PCR Technologies Market Breakdown by Vial Size
        • 10.1.2.12.3 Rest of Europe PCR Technologies Market Breakdown by Application
        • 10.1.2.12.4 Rest of Europe PCR Technologies Market Breakdown by End User

11. PCR Technologies Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the PCR Technologies Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Thermo Fisher Scientific Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Promega Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 QIAGEN NV
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 bioMerieux SA
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Hoffmann-La Roche Ltd
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Bio-Rad Laboratories Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Becton Dickinson and Co
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Takara Bio Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Standard Biotools Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Agilent Technologies Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Ellume Ltd
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. PCR Technologies Market Segmentation
  • Table 2. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Technology
  • Table 3. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Offerings
  • Table 4. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
  • Table 5. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
  • Table 6. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
  • Table 7. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Application
  • Table 8. PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By End User
  • Table 9. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 10. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 11. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 12. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 13. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 14. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 15. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 16. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 17. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 18. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 19. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 20. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 21. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 22. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 23. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 24. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 25. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 26. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 27. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 28. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 29. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 30. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 31. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 32. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 33. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 34. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 35. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 36. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 37. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 38. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 39. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 40. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 41. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 42. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 43. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 44. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Technology
  • Table 45. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Offerings
  • Table 46. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Instruments
  • Table 47. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Reagents and Consumables
  • Table 48. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Vial Size
  • Table 49. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By Application
  • Table 50. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn) - By End User
  • Table 51. Recent Inorganic Growth Strategies in the PCR Technologies Market
  • Table 52. Recent Organic Growth Strategies in the PCR Technologies Market
  • Table 53. Glossary of Terms, PCR Technologies Market

List Of Figures

  • Figure 1. PCR Technologies Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. PCR Technologies Market Revenue (US$ Million), 2020 - 2030
  • Figure 4. PCR Technologies Market Share (%) - By Technology, 2022 and 2030
  • Figure 5. Real Time PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Conventional PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. Reverse Transcription PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 8. Digital PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 9. Multiplex RT PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 10. Hot Start PCR Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. PCR Technologies Market Share (%) - By Offerings, 2022 and 2030
  • Figure 13. Reagents and Consumables Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 14. Instruments Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 15. Software and Services Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 16. PCR Technologies Market Share (%) - By Application, 2022 and 2030
  • Figure 17. Gene Expression Analysis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 18. Genetic Sequencing Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 19. Genotyping Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 20. Nucleic Acid Synthesis Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 21. Standard Validation Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 22. Point of Care Diagnostics Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 23. Environmental Application Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 24. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 25. PCR Technologies Market Share (%) - By End User, 2022 and 2030
  • Figure 26. Hospitals and Diagnostic Centers Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 27. Academia and Research Institutes Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 28. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 29. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 30. Europe: PCR Technologies Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. Europe PCR Technologies Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 32. Germany PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 33. United Kingdom PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 34. France PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 35. Italy PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 36. Spain PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 37. Rest of Europe PCR Technologies Market - Revenue and Forecast to 2030(US$ Mn)
  • Figure 38. Growth Strategies in the PCR Technologies Market